Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Monkeypox Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global monkeypox vaccine market is expected to exhibit a CAGR of 14.90% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Monkeypox is a zoonotic viral disease caused by the monkeypox virus, belonging to the Orthropox genus from the Poxviridae family. It can be transmitted through close contact with an infected person’s body fluids and contaminated items, such as bedding, respiratory droplets, lesions, etc. Some of the common symptoms of monkeypox include fever, headache, rashes that last up to three weeks, sore throat, coughing, and enlarged lymph nodes. Lesions, which typically appear one to three days after the commencement of a fever, last for around two to four weeks and are frequently characterized as painful until they begin to itch during the healing process.

Monkeypox Vaccine Market Trends:

The rising cases of monkeypox, resulting in the declaration of a public health emergency by WHO, are primarily driving the global monkeypox vaccine market. In line with this, the growing incidences of various chronic ailments and dermatology-related problems like eczema, which results in weak immunity and higher chances of getting infected with the monkeypox virus, are also propelling the product demand. Moreover, the increasing investments in extensive R&D activities by the government authorities for the introduction of novel monkeypox vaccines are further bolstering the market growth. For instance, the UK Health Security Agency (UKHSA) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) will receive funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to support the development of laboratory tools for evaluating monkeypox vaccines. Additionally, several government organizations are also launching favorable initiatives to spread awareness regarding disease prevention as well as the importance of immunization among the masses, especially in the endemic and rural regions. Besides this, the escalating utilization of genomic sequencing, which elucidates the specific infection-causing sequences and aid in the development of effective treatments, is expected to drive the global monkeypox vaccine market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global monkeypox vaccine market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, route of administration, distribution channel and end user.

Breakup by Type:

  • Replication-competent
  • Replication-deficient
     

Breakup by Route of Administration:

  • Subcutaneous
  • Percutaneous
     

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
     

Breakup by End User:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Type, Route of Administration, Distribution Channel, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global monkeypox vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global monkeypox vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global monkeypox vaccine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Monkeypox Vaccine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Replication-competent
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Replication-deficient
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Subcutaneous
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Percutaneous
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Clinics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players

List of Figures

Figure 1: Global: Monkeypox Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Monkeypox Vaccine Market: Breakup by Type (in %), 2021
Figure 5: Global: Monkeypox Vaccine Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Monkeypox Vaccine Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Monkeypox Vaccine Market: Breakup by End User (in %), 2021
Figure 8: Global: Monkeypox Vaccine Market: Breakup by Region (in %), 2021
Figure 9: Global: Monkeypox Vaccine (Replication-competent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Monkeypox Vaccine (Replication-competent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Monkeypox Vaccine (Replication-deficient) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Monkeypox Vaccine (Replication-deficient) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Monkeypox Vaccine (Subcutaneous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Monkeypox Vaccine (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Monkeypox Vaccine (Percutaneous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Monkeypox Vaccine (Percutaneous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Monkeypox Vaccine (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Monkeypox Vaccine (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Monkeypox Vaccine (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Monkeypox Vaccine (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Monkeypox Vaccine (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Monkeypox Vaccine (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Monkeypox Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Monkeypox Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Monkeypox Vaccine (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Monkeypox Vaccine (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Monkeypox Vaccine (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Monkeypox Vaccine (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Monkeypox Vaccine (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Monkeypox Vaccine (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Monkeypox Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Monkeypox Vaccine Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Monkeypox Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Monkeypox Vaccine Industry: SWOT Analysis
Figure 81: Global: Monkeypox Vaccine Industry: Value Chain Analysis
Figure 82: Global: Monkeypox Vaccine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Monkeypox Vaccine Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Monkeypox Vaccine Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Monkeypox Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Monkeypox Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Monkeypox Vaccine Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Monkeypox Vaccine Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Monkeypox Vaccine Market: Competitive Structure
Table 8: Global: Monkeypox Vaccine Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links